Stevens Capital Management LP Innoviva, Inc. Transaction History

Stevens Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$10.05 - $14.55 $192,346 - $278,472	-19,139 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$13.1 - $14.95 $250,720 - $286,128	19,139 New	19,139 $279,000
Q3 2018 Nov 13, 2018	SELL	$13.63 - $15.7 $180,270 - $207,648	-13,226 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$13.44 - $17.59 $177,757 - $232,645	13,226 New	13,226 $183,000
Q1 2018 May 08, 2018	SELL	$13.8 - $16.99 $193,834 - $238,641	-14,046 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$11.73 - $14.75 $32,351 - $40,680	-2,758 Reduced 16.41%	14,046 $199,000
Q3 2017 Nov 01, 2017	BUY	$12.06 - $14.12 $202,656 - $237,272	16,804	16,804 $237,000

240

77M

53.9K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.26B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.